甲状旁腺癌的外科诊治进展
Progress in Diagnosis and Surgical Treatment of Parathyroid Carcinoma
DOI: 10.12677/ACM.2023.131049, PDF,   
作者: 范家宁:哈尔滨医科大学第一临床医学院,黑龙江 哈尔滨
关键词: 甲状旁腺癌诊断治疗进展手术Parathyroid Carcinoma Diagnosis Treatment Progress Operation
摘要: 甲状旁腺癌(parathyroid carcinoma, PC)是一种罕见内分泌恶性肿瘤,其发病虽目前位于恶性肿瘤发生末位(占所有癌症比例的0.005%),但其一旦发生如果因为临床医师经验不足而造成诊治拖延与决策失误,便可能会给患者带来严重而不可逆的身体危害,故PC的临床诊断以及治疗方式有其重要研究价值。本文将甲状旁腺癌外科诊治过程的关键总结为“四不”,即诊前不忽视(应对PC的发生引起重视),诊中不单一(诊断技术选择不单一),术中不吝惜(绝不吝惜PC有可能侵犯的组织),才有可能最后做到术后不复发(实现不给患者带来二次手术及痛苦的希望)。笔者也将从此四个维度对甲状旁腺癌的外科诊治进展进行叙述,并对其综合治疗发展的前景进行展望。
Abstract: Parathyroid carcinoma (PC) is a rare endocrine malignant tumor. Although its incidence is at the end of malignant tumors (accounting for 0.005%), however, once it happens, if the diagnosis and treatment delay and decision-making errors are caused by the lack of clinicians’ experience, it may bring serious and irreversible physical harm to patients. Therefore, the clinical diagnosis and treatment of PC have important research value. In this paper, the key to the diagnosis and surgical treatment of parathyroid cancer is summarized as “four nos”, that is, do not ignore before diagnosis (pay attention to the occurrence of PC), do not single during diagnosis (the choice of diagnostic technology is not single), and do not spare during operation (do not spare the tissues that may be invaded by PC), so that it is possible to avoid recurrence after operation (realize the hope of not bringing secondary operation and pain to patients). The author will also describe the progress of diagnosis and surgical treatment of parathyroid carcinoma from these four dimensions, and pro-spect its comprehensive treatment.
文章引用:范家宁. 甲状旁腺癌的外科诊治进展[J]. 临床医学进展, 2023, 13(1): 325-330. https://doi.org/10.12677/ACM.2023.131049

参考文献

[1] Ullah, A., Khan, J., Waheed, A., Sharma, N., Pryor, E.K., Stumpe, T.R., Zarate, L.V., Cason, F.D., Kumar, S., Misra, S., Kavuri, S., Mesa, H, Roper, N., Foroutan, S., Karki, N.R., Del Rivero, J., Simonds, W.F. and Karim, N.A. (2022) Para-thyroid Carcinoma: Incidence, Survival Analysis, and Management: A Study from the SEER Database and Insights into Future Therapeutic Perspectives. Cancers, 14, Article No. 1426. [Google Scholar] [CrossRef] [PubMed]
[2] Riley, K. and Anzai, Y. (2022) Imaging of Treated Thyroid and Par-athyroid Disease. Neuroimaging Clinics of North America, 32, 145-157. [Google Scholar] [CrossRef] [PubMed]
[3] Rezkallah, E., Elsaify, A. and Elsaify, W. (2022) Parathyroid Carci-noma: Case Series Presentation. European Journal of Surgical Oncology, 48, e20. [Google Scholar] [CrossRef
[4] 中国研究型医院学会甲状旁腺及骨代谢疾病专业委员会, 中国研究型医院学会罕见病分会. 甲状旁腺癌诊治的专家共识[J]. 中华内分泌代谢杂志, 2019, 35(5): 361-368.
[5] Zhao, L., Liu, J.M., He, X.Y., Zhao, H.Y, Sun, L.H, Tao, B., Zhang, M.J., Chen, X., Wang, W.Q. and Ning, G. (2013) The Changing Clinical Patterns of Primary Hyperparathyroidism in Chinese Patients: Data from 2000 to 2010 in a Single Clinical Center. The Journal of Clinical Endocrinology and Metabolism, 98, 721-728. [Google Scholar] [CrossRef] [PubMed]
[6] Kowalski, G.J., Bednarczyk, A., Buła, G., Gawrychowska, A. and Gawrychowski, J. (2022) Parathyroid Carcinoma—A Study of 29 Cases. Endokrynologia Polska, 73, 56-63. [Google Scholar] [CrossRef
[7] 胡亚, 廖泉. 甲状旁腺癌外科治疗难点问题[J]. 中国实用外科杂志, 2020, 40(5): 508-510. [Google Scholar] [CrossRef
[8] Galata’, G., Hubbard, J., Talat, N., Anscomb, N., Klang, P., Al-Lawati, A., Aldrees, A. and Schulte, K.-M. (2022) Parathyroid Cancer: A Single Centre Experience of the Endocrine Surgical Care Group. British Journal of Surgery, 109, Article ID: znac056-029. [Google Scholar] [CrossRef
[9] Schulte, K.-M. and Talat, N. (2012) Diagnosis and Management of Parathyroid Cancer. Nature Reviews Endocrinology, 8, 612-622. [Google Scholar] [CrossRef] [PubMed]
[10] Goldner, E. and Fingeret, A. (2023) Parathyroid Carcinoma: A Na-tional Cancer Database Analysis. Journal of Surgical Research, 281, 57-62. [Google Scholar] [CrossRef] [PubMed]
[11] Feng, C.Z., Tian, C.W., Huang, L.Y., Chen, H.L., Feng, Y.Q. and Chang, S. (2022) A Bibliometric Analysis of the Landscape of Parathyroid Carcinoma Research Based on the PubMed (2000-2021). Frontiers in Oncology, 12, Article 824201. [Google Scholar] [CrossRef] [PubMed]
[12] Erickson, L.A., Mete, O., Juhlin, C.C., Perren, A. and Gill, A.J. (2022) Overview of 2022 WHO Classification of Parathyroid Tumors. Endocrine Pathology, 33, 64-89. [Google Scholar] [CrossRef] [PubMed]
[13] Swanith, A. (2022) An Overview on Parathyroid Cancer and Diagnosis. Journal of Oncology Research and Treatment, 7.
[14] Zhou, Z.K., Shi, Y., Li, C. and Wang, W. (2022) Primary Hyperparathyroidism-Induced Brown Tumors Caused by Parathyroid Carcinoma: A Case Report and Literature Review. Journal of International Medical Research, 50. [Google Scholar] [CrossRef
[15] Radzikowski, K.C., Rendl, G., Beheshti, M. and Pirich, C. (2022) 18F Choline PET/CT in a Patient with HRPT2 Mutation: Detecting Parathyroid Carcinoma Recurrence and Concomitant Breast Carcinoma. Nuklearmedizin-Nuclear Medicine, 61, 62-64. [Google Scholar] [CrossRef] [PubMed]
[16] Tao, M., Luo, S.Y., Wang, X.M., Jia, M. and Lu, X.B. (2022) A Nomogram Predicting the Overall Survival and Cancer-Specific Survival in Patients with Parathyroid Cancer: A Retrospective Study. Frontiers in Endocrinology, 13, Article 850457. [Google Scholar] [CrossRef] [PubMed]
[17] Ciregia, F., Cetani, F., Pardi, E., Soggiu, A., Piras, C., Zallocco, L., Borsari, S., Ronci, M., Caruso, V., Marcocci, C., Mazzoni, M.R., Lucacchini, A. and Giusti, L. (2021) Parathyroid Car-cinoma and Adenoma Co-Existing in One Patient: Case Report and Comparative Proteomic Analysis. Cancer Genomics & Proteomics, 18, 781-796. [Google Scholar] [CrossRef] [PubMed]
[18] 代文杰, 张爽. 原发性甲状旁腺功能亢进诊治进展[J]. 临床外科杂志, 2018, 26(6): 464-467.
[19] Hu, Y., Cui, M., Chang, X.Y., Wang, O., Chen, T.Q., Xiao, J.H., Wang, M.Y., Hua, S.R. and Liao, Q. (2022) Patterns and Predictors of Cervical Lymph Node Metastasis in Parathyroid Carcinoma. Cancers, 14, Article No. 4004. [Google Scholar] [CrossRef] [PubMed]
[20] Campennì, A. and Ruggeri, R.M. (2023) Letter to the Editor: Early Diagnosis of Parathyroid Carcinoma: A Challenging for Physicians. Clinical Endocrinology, 98, 273-274. [Google Scholar] [CrossRef] [PubMed]
[21] 蒋蕾, 周迎生. 甲状旁腺癌伴严重高钙血症1例[J]. 中国实用内科杂志, 2001(4): 213.
[22] Kada, S., Tanaka, M. and Yasoda, A. (2021) Parathyroid Carcinoma in a Patient with Secondary Hyperparathyroidism and Thyroid Hemiagenesis: A Case Report and Review of the Literature. Ear, Nose & Throat Journal. [Google Scholar] [CrossRef] [PubMed]
[23] Wei, B.J., Zhao, T., Shen, H., Jin, M.L., Zhou, Q., Liu, X., Wang, J.C. and Wang, Q. (2022) ASO Visual Abstract: Extended En Bloc Reoperation for Recurrent or Persistent Para-thyroid Carcinoma—Analysis of 31 Cases in a Single-Insti- tution Experience. Annals of Surgical Oncology, 29, 1218-1219. [Google Scholar] [CrossRef